Back
DBS Group Holdings Vs. Novo Nordisk AS Industry Stock Comparison
Buy
55
DBSDF
DBS Group Holdings
Last Price:
$31.22
Seasonality Move:
3.86%
Sell
20
NONOF
Novo Nordisk AS
Last Price:
$87.12
Seasonality Move:
8.64%
Buy
55
DBS Group Holdings (DBSDF)
is a Buy
Is DBS Group Holdings a Buy, Sell or Hold?
-
The current DBS Group Holdings [DBSDF] share price is $33.34. The Score for DBSDF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
DBSDF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $85.90. The Score for NONOF is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
DBSDF Stock Price Chart
What is DBS Group Holdings's stock price today?
-
The DBS Group Holdings share price today is $33.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBSDF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
DBSDF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 55.64 | Buy |
| Chaikin Money Flow: | 2427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.58 - 32.94) | Buy |
| Bollinger Bands (100): | (28.28 - 32.2) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.16 | Sell |
| Relative Strength Index (14 RSI): | 29.72 | Sell |
| Chaikin Money Flow: | 790 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.14 - 112.12) | Sell |
| Bollinger Bands (100): | (102.78 - 130.68) | Sell |
DBSDF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.42 | Buy |
| 20-day SMA: | 32.28 | Buy |
| 50-day SMA: | 31.54 | Buy |
| 200-day SMA: | 28.04 | Buy |
| 8-day EMA: | 32.53 | Buy |
| 20-day EMA: | 32.32 | Buy |
| 50-day EMA: | 31.6 | Buy |
| 200-day EMA: | 28.47 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 88.63 | Sell |
| 20-day SMA: | 100.89 | Sell |
| 50-day SMA: | 105.5 | Sell |
| 200-day SMA: | 124.76 | Sell |
| 8-day EMA: | 90.07 | Sell |
| 20-day EMA: | 97.13 | Sell |
| 50-day EMA: | 105.1 | Sell |
| 200-day EMA: | 116.2 | Sell |
DBS Group Holdings Earnings Growth & DBSDF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
DBS Group Holdings Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||